GlassScriptPhysician profile
Edwidge Cuvilly
NPI 1881834372
$1,513.95
in general payments reported to CMS, 2019-2025
15 companies · $515 in 2025
The $515 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $588 · 2022: $193 · 2023: $91.67 · 2024: $126 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640 · Education: $92.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.41 |
| Education | $92.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kadmon Pharmaceuticals LLC | $587.84 | 2021 | |
| Novartis Pharmaceuticals Corporation | $250.24 | 2022-2025 | |
| Incyte Corporation | $191.99 | 2022-2025 | |
| Daiichi Sankyo INC. | $71.33 | 2024-2025 | Vanflyta |
| Servier Pharmaceuticals LLC | $57.67 | 2023-2025 | |
| Glaxosmithkline, LLC. | $56.33 | 2024-2025 | Ojjaara |
| Astellas Pharma US INC | $55.96 | 2025 | Cresemba |
| Sobi, INC | $51.71 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.04 | 2023-2025 | Iclusig |
| Jazz Pharmaceuticals INC. | $29.17 | 2022 | |
| Merck Sharp & Dohme LLC | $27.07 | 2023 | |
| Blueprint Medicines Corporation | $26.03 | 2024 | Ayvakit |
| Alexion Pharmaceuticals, INC. | $25.47 | 2025 | Ultomiris |
| Stemline Therapeutics INC. | $24.55 | 2025 | Elzonris |
| Genentech USA, INC. | $15.55 | 2024 | Venclexta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwidge Cuvilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.